Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Circulating Tumor Microemboli Diagnostics for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Circulating Tumor DNA Provides a Sneak Peek Into Treatment Responses in Non–Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2019English

Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Small Cell Lung Cancer: Model of Circulating Tumor Cell Tumorospheres in Chemoresistance

Scientific Reports
Multidisciplinary
2017English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

P3.04-11 the Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Neutrophils Dominate the Immune Cell Composition in Non-Small Cell Lung Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Circulating Tumor DNA Evaluated by Next-Generation Sequencing Is Predictive of Tumor Response and Prolonged Clinical Benefit With Nivolumab in Advanced Non-Small Cell Lung Cancer

OncoImmunology
OncologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy